Home
About
Overview
Sharing Data
ORCID
Help
History (7)
LKB1 Down-Modulation by miR-17 Identifies Patients With NSCLC Having Worse Prognosis Eligible for Energy-Stress-Based Treatments.
Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors.
Patient-reported outcomes following pembrolizumab or placebo plus pemetrexed and platinum in patients with previously untreated, metastatic, non-squamous non-small-cell lung cancer (KEYNOTE-189): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial.
Tepotinib Treatment in Patients With MET Exon 14-Skipping Non-Small Cell Lung Cancer: Long-term Follow-up of the VISION Phase 2 Nonrandomized Clinical Trial.
Neoadjuvant or Perioperative Approach in Lung Cancer.
See All 7 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Neoadjuvant or Perioperative Approach in Lung Cancer.
Neoadjuvant or Perioperative Approach in Lung Cancer. N Engl J Med. 2024 05 16; 390(19):1816-1818.
View in:
PubMed
subject areas
Carcinoma, Non-Small-Cell Lung
Humans
Lung Neoplasms
Neoadjuvant Therapy
Perioperative Care
Pneumonectomy
authors with profiles
Marina Chiara Garassino